Search research articles
Contact Us
Filters
Showing results (1-10 of 231) with videos related to
Page
of 24
Sort By:
Clinical Chemistry
|
September 3, 1999
Uncovering rare mutations: an unforeseen complication of routine genotyping of APOE
R A Hegele
Circulation
|
May 23, 2001
Premature atherosclerosis associated with monogenic insulin resistance
R A Hegele
The Canadian Journal of Cardiology
|
December 1, 1992
Lipoprotein(a) and fibrinolysis
R A Hegele
Current Atherosclerosis Reports
|
December 21, 2000
Angiotensin-converting enzyme (ACE) inhibition in the secondary prevention of vascular disease: the Heart Outcomes Prevention Evaluation (HOPE) Trial and its substudies
R A Hegele
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
June 1, 1996
The role of lipids in cardiovascular disease: lessons from rare mutations and special populations
R A Hegele
The Canadian Journal of Cardiology
|
November 1, 1992
Lipoprotein(a): biochemistry and genetics
R A Hegele
International Journal of Clinical & Laboratory Research
|
January 1, 1997
The genetic basis of atherosclerosis
R A Hegele
Clinical Biochemistry
|
July 1, 1997
Is it time to measure Lp(a) as part of coronary heart disease risk assessment?
R A Hegele
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
October 1, 1989
Molecular forensics: applications, implications and limitations
R A Hegele
American Journal of Human Genetics
|
November 13, 2001
Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism
R A Hegele
Page
of 24
Search research articles
Search
Showing results (1-10 of 231) with videos related to
Sort By:
Page
of 24
Clinical Chemistry
|
September 3, 1999
Uncovering rare mutations: an unforeseen complication of routine genotyping of APOE
R A Hegele
Circulation
|
May 23, 2001
Premature atherosclerosis associated with monogenic insulin resistance
R A Hegele
The Canadian Journal of Cardiology
|
December 1, 1992
Lipoprotein(a) and fibrinolysis
R A Hegele
Current Atherosclerosis Reports
|
December 21, 2000
Angiotensin-converting enzyme (ACE) inhibition in the secondary prevention of vascular disease: the Heart Outcomes Prevention Evaluation (HOPE) Trial and its substudies
R A Hegele
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
June 1, 1996
The role of lipids in cardiovascular disease: lessons from rare mutations and special populations
R A Hegele
The Canadian Journal of Cardiology
|
November 1, 1992
Lipoprotein(a): biochemistry and genetics
R A Hegele
International Journal of Clinical & Laboratory Research
|
January 1, 1997
The genetic basis of atherosclerosis
R A Hegele
Clinical Biochemistry
|
July 1, 1997
Is it time to measure Lp(a) as part of coronary heart disease risk assessment?
R A Hegele
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
October 1, 1989
Molecular forensics: applications, implications and limitations
R A Hegele
American Journal of Human Genetics
|
November 13, 2001
Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism
R A Hegele
Page
of 24